All Pathways
Emergency MedicineEmergency

Acute Ischemic Stroke Management (AHA/ASA 2019)

Acute Ischemic Stroke Management (AHA/ASA 2019): Suspected Acute Stroke → Immediate Assessment → Non-Contrast CT Head → Hemorrhage on CT? → Hemorrhagic ...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Suspected Acute Stroke

    Sudden neurological deficit - activate stroke code

    1. Action

      Immediate Assessment

      ABCs, glucose, establish IV, time of onset

      • Determine LAST KNOWN WELL time (not when found)
      • Check blood glucose - treat if <60 or >400
      • Establish 2 large-bore IVs
      • 12-lead ECG
      • Activate stroke team/neurology
      1. Action

        Non-Contrast CT Head

        STAT - target door-to-CT <25 minutes

        • Rule out hemorrhage
        • Assess for early ischemic changes
        • Large hypodensity may contraindicate tPA
        • Consider CTA if LVO suspected
        1. Decision

          Hemorrhage on CT?

          Intracranial hemorrhage excludes thrombolysis

          1. Warning

            Hemorrhagic Stroke

            Different management - see ICH algorithm

            • Reverse anticoagulation if applicable
            • Blood pressure control
            • Neurosurgery consultation
            • ICU admission
          2. Action

            Calculate NIHSS

            NIH Stroke Scale score

            • Score 1-4: Minor stroke
            • Score 5-15: Moderate stroke
            • Score 16-20: Moderate-severe
            • Score >20: Severe stroke
            • Document for tPA eligibility and LVO screening
            1. Decision

              Symptom Onset ≤4.5 hours?

              tPA time window assessment

              • Standard window: 0-3 hours
              • Extended window: 3-4.5 hours (additional criteria)
              • Wake-up stroke: may qualify with perfusion imaging
              1. Decision

                tPA Contraindications?

                Review absolute and relative contraindications

                • ABSOLUTE: ICH history, recent surgery, active bleeding
                • RELATIVE: BP >185/110, INR >1.7, platelets <100k
                • 3-4.5hr additional: age >80, severe stroke, DM+prior stroke
                1. Action

                  IV Alteplase

                  0.9 mg/kg (max 90mg); 10% bolus, rest over 60min

                  • Target door-to-needle ≤60 minutes
                  • BP must be <185/110 before and <180/105 after
                  • No anticoagulants or antiplatelets for 24 hours
                  • Repeat NIHSS at 2hr and 24hr
                  • CT head at 24 hours before antiplatelets
                  1. Decision

                    Large Vessel Occlusion?

                    CTA or clinical suspicion

                    • NIHSS ≥6 suggests LVO
                    • Cortical signs (aphasia, neglect, gaze preference)
                    • CTA shows ICA, M1, or basilar occlusion
                    • Consider RACE, LAMS, or VAN screening
                    1. Action

                      Mechanical Thrombectomy

                      For LVO within 24 hours (selected patients)

                      • Standard window: 0-6 hours from LKW
                      • Extended window 6-24hr: DAWN/DEFUSE-3 criteria
                      • Transfer to thrombectomy-capable center
                      • Do NOT delay tPA for transfer
                      • Target door-to-groin ≤90 minutes
                      1. Action

                        Post-Treatment Care

                        Stroke unit admission

                        • Neuro checks q15min x 2hr, then q1hr x 6hr
                        • BP monitoring per protocol
                        • Dysphagia screening before oral intake
                        • PT/OT/Speech evaluation
                        • Secondary prevention workup
                        1. Action

                          Secondary Prevention

                          Prevent recurrent stroke

                          • Antiplatelets: ASA, clopidogrel, or DAPT
                          • Statin: high-intensity (atorvastatin 80mg)
                          • Atrial fibrillation: anticoagulation
                          • Carotid stenosis: consider CEA/CAS
                          • BP target <130/80 after acute phase
                          1. Outcome

                            Good Outcome

                            mRS 0-2 at 90 days

                          2. Outcome

                            Disability/Death

                            Rehabilitation, goals of care discussion

                2. Action

                  tPA Contraindicated

                  Document reason; proceed with other interventions

                  • Still evaluate for thrombectomy
                  • Aspirin 325mg within 24-48 hours
                  • Permissive HTN (up to 220/120)
                  • DVT prophylaxis

Guideline Source

Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Time windows are strict - document exact symptom onset time
  • tPA contraindications must be carefully reviewed
  • Large vessel occlusion screening requires additional assessment
  • Blood pressure targets differ for tPA-eligible vs non-eligible patients
  • Does not cover posterior circulation stroke nuances

Contraindicated Populations

pediatric

Applicable Regions

USEUInternational

EU: ESO guidelines largely concordant; tenecteplase increasingly used

US: Follow AHA/ASA guidelines; Get With The Guidelines participation recommended

International: Thrombectomy may not be available in all centers

Version 1Next review: 2027-01-01

Frequently Asked Questions

What is the Acute Ischemic Stroke Management (AHA/ASA 2019)?

The Acute Ischemic Stroke Management (AHA/ASA 2019) is a emergency clinical algorithm for Emergency Medicine. It provides a structured decision tree to guide clinical decision-making, based on Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines.

What guideline is the Acute Ischemic Stroke Management (AHA/ASA 2019) based on?

This algorithm is based on Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines (DOI: 10.1161/STR.0000000000000211).

What are the limitations of the Acute Ischemic Stroke Management (AHA/ASA 2019)?

Known limitations include: Time windows are strict - document exact symptom onset time; tPA contraindications must be carefully reviewed; Large vessel occlusion screening requires additional assessment; Blood pressure targets differ for tPA-eligible vs non-eligible patients; Does not cover posterior circulation stroke nuances. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Acute Ischemic Stroke Management (AHA/ASA 2019) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free